PDF(469 KB)
Research progress in biological function of chitooligosaccharide and its application in biomedical field
Shaoru WANG,Yungang LUO
PDF(469 KB)
PDF(469 KB)
Research progress in biological function of chitooligosaccharide and its application in biomedical field
)Chitooligosaccharides （COS）， as the degradation products of the natural polysaccharide chitosan （CS）， retain the good biocompatibility， non-toxicity， and biodegradability of CS. Additionally， due to the shortened sugar chains and reduced molecular weight， their water solubility and bioactivity are improved， making them more easily absorbed and utilized by organisms. In recent years， COS has received increasing attention. While there are numerous studies on the biological functions of CS and its applications in the biomedical field， the research on the functions and applications of COS is relatively limited. This study summarizes and analyzes the main biological functions of COS （anti-inflammatory， anti-tumor， antibacterial， and tissue regeneration promotion） and their possible mechanisms. It also discusses the research progress in the applications of COS in the biomedical field， in order to provide the theoretical basis and reference for the further research and broader application of COS in biomedicine.
Chitooligosaccharide / Chitosan / Biological function / Biomedical application / Tissue regeneration
R318.05
| 1 | XIA W S， LIU P， ZHANG J L， et al. Biological activities of chitosan and chitooligosaccharides［J］. Food Hydrocoll， 2011， 25（2）： 170-179. |
| 2 | LI Z H， YANG F， YANG R D. Synthesis and characterization of chitosan derivatives with dual-antibacterial functional groups［J］. Int J Biol Macromol， 2015， 75： 378-387. |
| 3 | 章中华， 王 毅， 李永贵， 等. 壳聚糖在生物医学应用中的研究进展［J］. 生物医学工程研究， 2022， 41（3）： 347-352. |
| 4 | BANO I， ARSHAD M， YASIN T， et al. Chitosan： a potential biopolymer for wound management［J］. Int J Biol Macromol， 2017， 102： 380-383. |
| 5 | 丁鑫鑫， 周延民， 相星辰， 等. 壳聚糖复合材料在骨组织工程中的研究进展［J］. 华西口腔医学杂志， 2018， 36（4）： 441-446. |
| 6 | AUGUSTINE R， REHMAN S R U， AHMED R， et al. Electrospun chitosan membranes containing bioactive and therapeutic agents for enhanced wound healing［J］. Int J Biol Macromol， 2020， 156： 153-170. |
| 7 | LEE J Y， TERMSARASAB U， LEE M Y， et al. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery［J］. Acta Biomater， 2017， 57： 262-273. |
| 8 | TABASSUM N， AHMED S， ALI M A. Chitooligosaccharides and their structural-functional effect on hydrogels： a review［J］. Carbohydr Polym， 2021， 261： 117882. |
| 9 | JAFARI H， BERNAERTS K V， DODI G， et al. Chitooligosaccharides for wound healing biomaterials engineering［J］. Mater Sci Eng C Mater Biol Appl， 2020， 117： 111266. |
| 10 | HUANG X H， CHEN M， WU H M， et al. Macrophage polarization mediated by chitooligosaccharide （COS） and associated osteogenic and angiogenic activities［J］. ACS Biomater Sci Eng， 2020， 6（3）： 1614-1629. |
| 11 | PAN Z， CHENG D D， WEI X J， et al. Chitooligosaccharides inhibit tumor progression and induce autophagy through the activation of the p53/mTOR pathway in osteosarcoma［J］. Carbohydr Polym， 2021， 258： 117596. |
| 12 | NIU X L， WEI Y， LIU Q H， et al. Silver-loaded microspheres reinforced chitosan scaffolds for skin tissue engineering［J］. Eur Polym J， 2020， 134： 109861. |
| 13 | VO T S， KONG C S， KIM S K. Inhibitory effects of chitooligosaccharides on degranulation and cytokine generation in rat basophilic leukemia RBL-2H3 cells［J］. Carbohydr Polym， 2011， 84（1）： 649-655. |
| 14 | TRAN A X， WHITFIELD C. Lipopolysaccharides （endotoxins）［A］.Encyclopedia of Microbiology［M］. Amsterdam： Elsevier， 2009： 513-528. |
| 15 | LIU H T， LI W M， LI X Y， et al. Chitosan oligosaccharides inhibit the expression of interleukin-6 in lipopolysaccharide-induced human umbilical vein endothelial cells through p38 and ERK1/2 protein kinases［J］. Basic Clin Pharmacol Toxicol， 2010， 106（5）： 362-371. |
| 16 | LIU H T， HUANG P， MA P， et al. Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases［J］. Acta Pharmacol Sin， 2011， 32（4）： 478-486. |
| 17 | LI Y， LIU H T， XU Q S， et al. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response［J］. Carbohydr Polym， 2014， 99： 568-578. |
| 18 | GUO C C， ZHANG Y， LING T， et al. Chitosan oligosaccharides alleviate colitis by regulating intestinal microbiota and PPARγ/SIRT1-mediated NF-κB pathway［J］. Mar Drugs， 2022， 20（2）： 96. |
| 19 | 杨院平. 抗炎天然产物壳寡糖对炎性肠病保护作用的实验研究［D］. 武汉： 武汉大学， 2015. |
| 20 | LI S L， LIU J， LIU S Y， et al. Chitosan oligosaccharides packaged into rat adipose mesenchymal stem cells-derived extracellular vesicles facilitating cartilage injury repair and alleviating osteoarthritis［J］. J Nanobiotechnol， 2021， 19（1）： 343. |
| 21 | MARTINEZ F O， GORDON S. The M1 and M2 paradigm of macrophage activation： time for reassessment［J］. F1000Prime Rep， 2014， 6： 13. |
| 22 | STEIN M， KESHAV S， HARRIS N， et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity： a marker of alternative immunologic macrophage activation［J］. J Exp Med， 1992， 176（1）： 287-292. |
| 23 | SAHARIAH P， MáSSON M. Antimicrobial chitosan and chitosan derivatives： a review of the structure-activity relationship［J］. Biomacromolecules， 2017， 18（11）： 3846-3868. |
| 24 | YU D W， FENG J Y， YOU H M， et al. The microstructure， antibacterial and antitumor activities of chitosan oligosaccharides and derivatives［J］. Mar Drugs， 2022， 20（1）： 69. |
| 25 | HARVEY A L， EDRADA-EBEL R， QUINN R J. The re-emergence of natural products for drug discovery in the genomics era［J］. Nat Rev Drug Discov， 2015， 14（2）： 111-129. |
| 26 | SALAH R， MICHAUD P， MATI F， et al. Anticancer activity of chemically prepared shrimp low molecular weight chitin evaluation with the human monocyte leukaemia cell line， THP-1［J］. Int J Biol Macromol， 2013， 52： 333-339. |
| 27 | MATTAVEEWONG T， WONGKRASANT P， CHANCHAI S， et al. Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-κB and mTOR signaling［J］. Carbohydr Polym， 2016， 145： 30-36. |
| 28 | CHEN J S， ZHOU Z G， ZHENG C J， et al. Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy［J］. Carbohydr Polym， 2022， 277： 118869. |
| 29 | RATANAVARAPORN J， DAMRONGSAKKUL S， KANOKPANONT S， et al. Osteogenic differentiation of bone-marrow-derived stem cells cultured with mixed gelatin and chitooligosaccharide scaffolds ［J］. J Biomater Sci Polym Ed， 2011， 22（8）： 1083-1098. |
| 30 | CHANDIKA P， KO S C， OH G W， et al. Fish collagen/alginate/chitooligosaccharides integrated scaffold for skin tissue regeneration application［J］. Int J Biol Macromol， 2015， 81： 504-513. |
| 31 | WU J， XIAO Z C， CHEN A Q， et al. Sulfated zwitterionic poly（sulfobetaine methacrylate） hydrogels promote complete skin regeneration［J］. Acta Biomater， 2018， 71： 293-305. |
| 32 | HUANG Q L， OUYANG Z X， TAN Y N， et al. Activating macrophages for enhanced osteogenic and bactericidal performance by Cu ion release from micro/nano-topographical coating on a titanium substrate［J］. Acta Biomater， 2019， 100： 415-426. |
| 33 | LIU W， LI J H， CHENG M Q， et al. A surface-engineered polyetheretherketone biomaterial implant with direct and immunoregulatory antibacterial activity against methicillin-resistant Staphylococcus aureus［J］. Biomaterials， 2019， 208： 8-20. |
| 34 | SPILLER K L， NASSIRI S， WITHEREL C E， et al. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds［J］. Biomaterials， 2015， 37： 194-207. |
| 35 | HUANG X H， GUO X， QU L T， et al. Gradient regulation of osteo-immune microenvironment by chitooligosaccharide-containing ion-doped mesoporous silica nanoparticles to accelerate osteogenesis［J］. Appl Mater Today， 2021， 23： 101067. |
| 36 | GARCíA M A， DE LA PAZ N， CASTRO C， et al. Effect of molecular weight reduction by gamma irradiation on the antioxidant capacity of chitosan from lobster shells［J］. J Radiat Res Appl Sci， 2015， 8（2）： 190-200. |
| 37 | ZHOU X， ZHANG X S， ZHOU J J， et al. An investigation of chitosan and its derivatives on red blood cell agglutination［J］. RSC Adv， 2017， 7（20）： 12247-12254. |
| 38 | HO T T， DOAN V K， TRAN N M， et al. Fabrication of chitosan oligomer-coated electrospun polycaprolactone membrane for wound dressing application［J］. Mater Sci Eng C Mater Biol Appl， 2021， 120： 111724. |
| 39 | EL-HAMMADI M M， DELGADO á V， MELGUIZO C， et al. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil［J］. Int J Pharm， 2017， 516（1/2）： 61-70. |
| 40 | HU X C， CHEN S M， YIN H， et al. Chitooligosaccharides-modified PLGA nanoparticles enhance the antitumor efficacy of AZD9291 （Osimertinib） by promoting apoptosis［J］. Int J Biol Macromol， 2020， 162： 262-272. |
| 41 | SETTEN R L， ROSSI J J， HAN S P. The current state and future directions of RNAi-based therapeutics［J］. Nat Rev Drug Discov， 2019， 18（6）： 421-446. |
| 42 | ZHENG X L， ZHU Y， FEI W D， et al. Redox-responsive and electrically neutral PLGA nanoparticles for siRNA delivery in human cervical carcinoma cells［J］. J Pharm Innov， 2022， 17（4）： 1392-1404. |
| 43 | LIU X， CHEN L Q， ZHANG Y Y， et al. Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNA［J］. Eur J Pharm Sci， 2021， 158： 105641. |
| 44 | CHANDIKA P， OH G W， HEO S Y， et al. Electrospun porous bilayer nano-fibrous fish collagen/PCL bio-composite scaffolds with covalently cross-linked chitooligosaccharides for full-thickness wound-healing applications［J］. Mater Sci Eng C Mater Biol Appl， 2021， 121： 111871. |
| 45 | ZHOU L Z， CAI L， RUAN H J， et al. Electrospun chitosan oligosaccharide/polycaprolactone nanofibers loaded with wound-healing compounds of Rutin and Quercetin as antibacterial dressings［J］. Int J Biol Macromol， 2021， 183： 1145-1154. |
| 46 | LUO C， LIU W J， LUO B H， et al. Antibacterial activity and cytocompatibility of chitooligosaccharide-modified polyurethane membrane via polydopamine adhesive layer［J］. Carbohydr Polym， 2017， 156： 235-243. |
| 47 | LI C W， WANG Q， LI J， et al. Silver nanoparticles/chitosan oligosaccharide/poly（vinyl alcohol） nanofiber promotes wound healing by activating TGFβ1/Smad signaling pathway［J］. Int J Nanomedicine， 2016， 11： 373-386. |
| 48 | YIN N， DU R P， ZHAO F K， et al. Characterization of antibacterial bacterial cellulose composite membranes modified with chitosan or chitooligosaccharide［J］. Carbohydr Polym， 2020， 229： 115520. |
| 49 | CHANDIKA P， KIM M S， KHAN F， et al. Wound healing properties of triple cross-linked poly （vinyl alcohol）/methacrylate kappa-carrageenan/chitooligosaccharide hydrogel［J］. Carbohydr Polym， 2021， 269： 118272. |
| 50 | ALIDADI S， ORYAN A， BIGHAM-SADEGH A， et al. Comparative study on the healing potential of chitosan， polymethylmethacrylate， and demineralized bone matrix in radial bone defects of rat［J］. Carbohydr Polym， 2017， 166： 236-248. |
| 51 | PARK H H， KO S C， OH G W， et al. Characterization and biological activity of PVA hydrogel containing chitooligosaccharides conjugated with Gallic acid［J］. Carbohydr Polym， 2018， 198： 197-205. |
| 52 | ZHAO D， SHI C， GUO T T， et al. Multifunctional gel films of marine polysaccharides cross-linked with poly-metal ions for wound healing［J］. Pharmaceuticals， 2022， 15（6）： 750. |
| 53 | RATANAVARAPORN J， KANOKPANONT S， TABATA Y， et al. Modulation of in vitro attachment， proliferation and osteogenic differentiation of rat bone-marrow-derived stem cells using different molecular mass chitosans and their blends with gelatin［J］. J Biomater Sci Polym Ed， 2010， 21（8/9）： 979-996. |
| 54 | THITISET T， DAMRONGSAKKUL S， YODMUANG S， et al. A novel gelatin/chitooligosaccharide/demineralized bone matrix composite scaffold and periosteum-derived mesenchymal stem cells for bone tissue engineering［J］. Biomater Res， 2021， 25（1）： 19. |
| 55 | WANG B， TAN L， DENG D P， et al. Novel stable cytokine delivery system in physiological pH solution： chitosan oligosaccharide/heparin nanoparticles［J］. Int J Nanomed， 2015， 10： 3417-3427. |
| 56 | WANG B， GUO Y W， CHEN X F， et al. Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2［J］. Int J Nanomed， 2018， 13： 7395-7408. |
/
| 〈 |
|
〉 |
AI Summary
